Procedure: embryonic dopamine cell implant surgery (DrugBank: Dopamine)
3 diseases| 告示番号 | 疾患名(ページ内リンク) | 臨床試験数 | 
|---|---|---|
| 6 | パーキンソン病 | 1 | 
| 7 | 大脳皮質基底核変性症 | 0 | 
| 74 | 下垂体性PRL分泌亢進症 | 0 | 
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00038116 (ClinicalTrials.gov) | May 1995 | 29/5/2002 | Embryonic Dopamine Cell Implants for Parkinson's Disease | Embryonic Dopamine Cell Implants for Parkinson's Disease: A Double-Blind Study | Parkinson Disease | Procedure: embryonic dopamine cell implant surgery;Procedure: placebo | University of Colorado, Denver | NULL | Completed | 20 Years | 75 Years | Both | 40 | Phase 3 | United States |